NEOGEN CORP·4/A

Jan 29, 10:30 AM ET

Ranalli Tamara A. 4/A

4/A · NEOGEN CORP · Filed Jan 29, 2026

Research Summary

AI-generated summary of this filing

Updated

NEOGEN (NEOG) SVP Tamara Ranalli Receives Stock Awards

What Happened

  • Tamara A. Ranalli, Senior Vice President of NEOGEN Corp (NEOG), was granted equity awards on 2026-01-07: two awards of 50,813 shares each at $7.38 (each valued at $375,000) and a grant of 261,210 performance-based units reported as a derivative at $0.00. The two 50,813-share awards total 101,626 shares (~$750,000 at the $7.38 reference), while the 261,210 PSUs are performance-conditioned and show $0 reported value at grant.

Key Details

  • Transaction date: 2026-01-07 (reported on an amended Form 4 filed 2026-01-29).
  • Award entries: 50,813 shares @ $7.38 (x2) — each reported value $375,000; 261,210 units @ $0.00 (derivative / PSUs).
  • Shares owned after transaction: not specified in the provided filing.
  • Footnotes: F1 — Options and RSUs (the non-PSU awards) vest in equal annual installments on each of the first three anniversaries of the grants. F2 — PSUs vest in full at the three-year anniversary (performance conditions may apply).
  • Filing status: This is an amended filing dated Jan 29 for Jan 7 transactions; the amendment and the 22-day gap suggest the original Form 4 was updated or filed late relative to the standard Form 4 reporting window.

Context

  • These transactions are compensation grants (awards/PSUs), not open-market purchases or sales; such grants are routine for executives and reflect company compensation practices rather than immediate buy/sell market sentiment. PSUs are performance-based and typically convert to shares only if specific targets are met and after the vesting period; the RSU/option-style awards vest over three years per the footnote.

Insider Transaction Report

Form 4/AAmended
Period: 2026-01-07
Ranalli Tamara A.
Senior Vice President
Transactions
  • Award

    Common Stock

    [F1]
    2026-01-07$7.38/sh+50,813$375,00050,813 total
  • Award

    Common Stock

    [F2]
    2026-01-07$7.38/sh+50,813$375,00050,813 total
  • Award

    Common Stock (Right to Buy)

    [F1]
    2026-01-07+261,210261,210 total
    Exercise: $7.38Exp: 2036-01-07Common Stock (261,210 underlying)
Footnotes (2)
  • [F1]Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
  • [F2]PSUs vest in total at the end of the three year anniversary date of the grant
Signature
Christopher Sefcheck (Attorney in Fact)|2026-01-29

Documents

1 file
  • 4
    primary_doc.xml

    PRIMARY DOCUMENT